Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Postabortion Contraceptive Use and LARC Access

Obstet Gynecol; ePub 2017 Mar 6; Goyal, et al

Women with access to no-cost long-acting reversible contraception (LARC) were more likely to use and continue these methods after induced abortion compared to women who were not eligible to participate in a specialized funding program that provided LARC at no cost, a recent study found. This prospective study of 518 abortion patients at Planned Parenthood in Austin, TX, between October 2014 and March 2016 compared postabortion LARC use among women who were eligible for the specialized funding program and 2 groups who were ineligible. Researchers found:

  • Preabortion preference for LARC was high among all 3 groups.
  • Low-income ineligible women were more likely to use less effective contraception and become pregnant.
  • Low-income eligible participants had a 10-fold greater incidence of receiving postabortion LARC compared with low-income ineligible participants.
  • 1-year continuation was 90% among low-income eligible and higher income women who received postabortion LARC.

Citation:

Goyal V, Canfield C, Aiken ARA, Dermish A, Potter JE. Postabortion contraceptive use and continuation when long-acting reversible contraception is free. [Published online ahead of print March 6, 2017]. Obstet Gynecol. doi:10.1097/AOG.0000000000001926.